Valuation: Genesis Fertility Center

Market Cap 433M 12.79M 11.59M 10.72M 9.67M 18.23M 1.21B 18.87M 129M 51.06M 644M 48M 46.98M 2.04B P/E 2026 *
28.1x
P/E 2027 * 24.6x
Enterprise Value 433M 12.79M 11.59M 10.72M 9.67M 18.23M 1.21B 18.87M 129M 51.06M 644M 48M 46.98M 2.04B EV / Sales 2026 *
1.25x
EV / Sales 2027 * 1.18x
Free-Float
16.62%
Yield 2026 *
2.54%
Yield 2027 * 2.54%
11-09 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
08-11 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-10 Genesis Fertility Center Public Company Limited Announces Interim Cash Dividend, Payable on September 8, 2026 CI
05-14 Genesis Fertility Center Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-14 Genesis Fertility Center Public Company Limited Announces Board and Committee Changes CI
02-23 Genesis Fertility Center Public Company Limited Proposes Cash Dividend for the Year Ended 31 December 2025, Payable on 26 May 2026 CI
02-23 Genesis Fertility Center Public Company Limited Announces Changes in Committee Compositions, Effective February 23, 2026 CI
02-23 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
12-17 Genesis Fertility Center Public Company Limited Announces Board and Committee Resignations, Effective December 16, 2025 CI
11-10 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
16/09/25 Genesis Fertility Center appoints Nathee Tungchitsodsai as CEO RE
16/09/25 Genesis Fertility Center Public Company Limited Announces Appointment of Nathee Tungchitsodsai as Chief Executive Officer, Effective 16 October 2025 CI
13/09/25 90,750,000 Common Shares of Genesis Fertility Center Public Company Limited are subject to a Lock-Up Agreement Ending on 13-SEP-2025. CI
1 week-1.01%
Current month+0.51%
1 month-4.37%
3 months-7.94%
6 months-29.64%
Current year-34.33%
1 week 1.91
Extreme 1.91
2
1 month 1.91
Extreme 1.91
2.08
Current year 1.91
Extreme 1.91
3.18
1 year 1.91
Extreme 1.91
3.24
3 years 1.91
Extreme 1.91
13.3
5 years 1.91
Extreme 1.91
13.3
10 years 1.91
Extreme 1.91
13.3
Manager TitleAgeSince
Chief Executive Officer - 16/10/2025
Director of Finance/CFO 48 01/01/2020
Chief Operating Officer 43 08/12/2016
Director TitleAgeSince
Chairman 57 08/12/2016
Director/Board Member 53 16/11/2021
Director/Board Member 57 08/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
02/12/24 Others

Director

1,400,000 0.6364%
29/11/24 Buy

Founder

9,400 0.0043%
27/11/24 Others

Director

1,400,000 0.6364%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.01%-31.60%-80.87% 12.79M
-0.49%+6.56%+12.76%+31.78% 114B
-0.32%+0.82%+5.44%+116.99% 104B
-1.19%+2.71%+59.01%+557.38% 46.27B
+0.89%+1.54%+8.69%+105.75% 33.33B
-0.49%+1.07%+38.31%+81.24% 30.08B
-0.02%+1.55%+38.39%+96.15% 28.56B
-0.29%+0.95%+45.44%+421.29% 22.76B
+0.33%-1.02%-18.35%-17.59% 19.92B
+1.15%+2.99%-3.88%+34.63% 17.15B
Average -0.04%+1.62%+15.42%+134.67% 42B
Weighted average by Cap. -0.26%+2.74%+18.95%+144.40%

Financials

2026 *2027 *
Net sales 346M 10.21M 9.25M 8.56M 7.72M 14.55M 963M 15.06M 103M 40.77M 514M 38.32M 37.5M 1.63B 368M 10.86M 9.84M 9.1M 8.21M 15.48M 1.02B 16.02M 109M 43.36M 547M 40.75M 39.89M 1.74B
Net income 15M 443K 401K 371K 335K 631K 41.74M 653K 4.46M 1.77M 22.3M 1.66M 1.63M 70.77M 17M 502K 455K 420K 379K 715K 47.3M 740K 5.05M 2M 25.27M 1.88M 1.84M 80.21M
Net Debt - -
Projected Income Statement - Annual - Genesis Fertility Center
Logo Genesis Fertility Center
Genesis Fertility Center PCL is a Thailand-based company engaged in the healthcare sector, primarily providing fertility and reproductive healthcare services. The Company provides treatment and counseling services to infertile people, chromosome analysis by NGS technique services and provide investment services in other businesses, consulting and management services. The Company provides assisted reproductive technology services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI) and Intrauterine Insemination (IUI). Its service offerings also include Frozen Embryo Transfer (FET), egg freezing services and Preimplantation Genetic Testing for Aneuploidy (PGT-A) using laboratory-based screening methods. The Company serves both domestic and international patients through its network of fertility clinics and healthcare facilities. The Company operates through its subsidiaries such as Genosomics Company Limited, GFC Fertility Group Company Limited, and others.
Employees
-
Date Price Change Volume
13/11/26 THB 1.970 0.00% 13,300
12/11/26 THB 1.970 -0.51% 9,400
11/11/26 THB 1.980 -0.50% 35,700
10/11/26 THB 1.990 0.00% 29,101
09/11/26 THB 1.990 0.00% 4,302